Debiopharm International SA Selects Veeva Vault eTMF for eTMF Collaboration


Applied Clinical Trials

Veeva Systems announced that Debiopharm International SA, part of Swiss-based biopharmaceutical company Debiopharm Group™, has selected Veeva Vault eTMF for eTMF collaboration on a single, cloud-based application. Previously, Debiopharm’s external partners were unable to access the company's on-premise eTMF, so CROs used their own systems and transferred documents periodically.

Read the full release here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.